The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - E.R. Squibb Sons, LLC
Clinical and molecular characteristics of advanced esophageal/GEJ cancer with brain metastasis.
 
Kai-li Liang
No Relationships to Disclose
 
Josephine Louella Feliciano
Consulting or Advisory Role - AstraZeneca/Merck; Bristol-Myers Squibb; Genentech; Lilly; Merck; Pfizer
Research Funding - AstraZeneca/Merck (Inst); Bristol-Myers Squibb (Inst); Genentech; Merck
 
Kristen Marrone
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca; Janssen; Mirati Therapeutics; Puma Biotechnology
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Mirati Therapeutics
 
Joseph Christopher Murray
No Relationships to Disclose
 
Sean Tackett
No Relationships to Disclose
 
Russell K. Hales
Speakers' Bureau - Peerview
Research Funding - Genentech
 
K. Ranh Voong
Consulting or Advisory Role - AstraZeneca/Merck
 
Richard James Battafarano
No Relationships to Disclose
 
Stephen Yang
Honoraria - Medical Device Business Services, Inc
Travel, Accommodations, Expenses - Intuitive Surgical
 
Stephen Broderick
Consulting or Advisory Role - AstraZeneca/Merck; Bristol Myers Squibb Foundation (Inst); E.R. Squibb Sons, LLC
 
Jinny Suk Ha
Travel, Accommodations, Expenses - Intuitive Surgical
 
Patrick M. Forde
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; F-Star Biotechnology; G1 Therapeutics; Genentech; ITeos Therapeutics; Janssen; Novartis; Sanofi; Surface Oncology
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals; Kyowa Hakko Kirin (Inst); Novartis (Inst)
 
Julie R. Brahmer
Honoraria - Janssen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech; GlaxoSmithKline; Lilly; Merck; Regeneron; Sanofi; Turning Point Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); RAPT Therapeutics (Inst); Revolution (Inst); Spectrum Pharmaceuticals (Inst)
Other Relationship - Bristol-Myers Squibb
 
Vincent K. Lam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Seagen; Takeda; Takeda
Research Funding - BMS (Inst); GlaxoSmithKline (Inst); Merck (Inst); Seagen (Inst)